Infliximab-dyyb

Infliximab-dyyb is a prescription medication used to treat Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Infliximab-dyyb belongs to a group of drugs called tumor necrosis factor-alpha inhibitors. These work by blocking the action of a substance in the body that causes inflammation.

This medication is available in an injectable form to be given directly into a vein (IV) by a healthcare professional.

Common side effects of infliximab-dyyb include infections, headache, and stomach pain.

Infliximab-dyyb is a prescription medication used to treat:

• moderate to severe active Crohn’s disease who have had an inadequate response to conventional therapy in adults and children (six years and older)
• moderate to severe active ulcerative colitis who have had an inadequate response to conventional therapy in adults
• moderate to severe active rheumatoid arthritis (to be given with methotrexate)
• active ankylosing spondylitis (arthritis of the spine)
• active psoriatic arthritis;
• chronic severe plaque psoriasis in adults 

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Infliximab-dyyb may be found in some form under the following brand names:

• Inflectra

Serious side effects have been reported with infliximab- dyyb. See the “Infliximab- dyyb Precautions” section.